Studies on slow release antibiotic middle ear pellets

Otitis Media with Effusion (OME) is the commonest cause of paediatric hearing impairment globally. Antibiotic laden pellets placed in the middle ear (ME) present a potential novel treatment strategy for OME disrupting the middle ear biofilm and avoiding systemic side effects. In vitro studies of Sta...

Full description

Bibliographic Details
Main Author: Hoskison, Emma
Format: Thesis (University of Nottingham only)
Language:English
Published: 2019
Subjects:
Online Access:https://eprints.nottingham.ac.uk/56413/
_version_ 1848799326318362624
author Hoskison, Emma
author_facet Hoskison, Emma
author_sort Hoskison, Emma
building Nottingham Research Data Repository
collection Online Access
description Otitis Media with Effusion (OME) is the commonest cause of paediatric hearing impairment globally. Antibiotic laden pellets placed in the middle ear (ME) present a potential novel treatment strategy for OME disrupting the middle ear biofilm and avoiding systemic side effects. In vitro studies of Staphylococcus Aureus biofilm eradication with pellets laden with rifampicin and clindamycin demonstrate a future potential OME treatment and this study aims to establish the safety of these pellets in vivo. Rifampicin (1.8mM) and clindamycin (35.3mM) loaded pellets made of poly lactic-co-glycolic acid and pluronic were surgically placed in guinea pig middle ears. Auditory Brainstem Responses (ABRs) thresholds between 8-30 kHz were tested over 16 weeks alongside controls to assess for ototoxicity; amplitudes and latencies studied to assess for neurotoxicity. At one week post insertion of antibiotic laden pellets, marked ABR threshold elevation (15-40 dB) was observed and persisted (25-40 dB) at week 16 without accompanying changes in ABR wave amplitudes and latencies. This pattern therefore does not support a neurotoxic mechanism. Representative cytocochleograms and immunofluorescence of the cochleas did not exhibit any appreciable frank outer or inner hair cell loss from the guinea pigs loaded with rifampicin and clindamycin pellets. This suggests that the pellets are not causing threshold elevation via an ototoxic mechanism. ME histology revealed pellet remnants causing a moderate inflammatory response persisting at 16 weeks. With evidence of chronic inflammation in the middle ear, an associated ME effusion which has been undetected experimentally may underlie the ABR threshold elevation seen with rifampicin and clindamycin laden pellets. Confined to the middle ear, this may also explain the lack of IHC and OHC damage. As a delivery vehicle to the ME, PLGA and Pluronic pellets have potential, but further studies are required on their antibiotic carriage to the middle ear before in vivo use.
first_indexed 2025-11-14T20:33:53Z
format Thesis (University of Nottingham only)
id nottingham-56413
institution University of Nottingham Malaysia Campus
institution_category Local University
language English
last_indexed 2025-11-14T20:33:53Z
publishDate 2019
recordtype eprints
repository_type Digital Repository
spelling nottingham-564132025-02-28T14:27:52Z https://eprints.nottingham.ac.uk/56413/ Studies on slow release antibiotic middle ear pellets Hoskison, Emma Otitis Media with Effusion (OME) is the commonest cause of paediatric hearing impairment globally. Antibiotic laden pellets placed in the middle ear (ME) present a potential novel treatment strategy for OME disrupting the middle ear biofilm and avoiding systemic side effects. In vitro studies of Staphylococcus Aureus biofilm eradication with pellets laden with rifampicin and clindamycin demonstrate a future potential OME treatment and this study aims to establish the safety of these pellets in vivo. Rifampicin (1.8mM) and clindamycin (35.3mM) loaded pellets made of poly lactic-co-glycolic acid and pluronic were surgically placed in guinea pig middle ears. Auditory Brainstem Responses (ABRs) thresholds between 8-30 kHz were tested over 16 weeks alongside controls to assess for ototoxicity; amplitudes and latencies studied to assess for neurotoxicity. At one week post insertion of antibiotic laden pellets, marked ABR threshold elevation (15-40 dB) was observed and persisted (25-40 dB) at week 16 without accompanying changes in ABR wave amplitudes and latencies. This pattern therefore does not support a neurotoxic mechanism. Representative cytocochleograms and immunofluorescence of the cochleas did not exhibit any appreciable frank outer or inner hair cell loss from the guinea pigs loaded with rifampicin and clindamycin pellets. This suggests that the pellets are not causing threshold elevation via an ototoxic mechanism. ME histology revealed pellet remnants causing a moderate inflammatory response persisting at 16 weeks. With evidence of chronic inflammation in the middle ear, an associated ME effusion which has been undetected experimentally may underlie the ABR threshold elevation seen with rifampicin and clindamycin laden pellets. Confined to the middle ear, this may also explain the lack of IHC and OHC damage. As a delivery vehicle to the ME, PLGA and Pluronic pellets have potential, but further studies are required on their antibiotic carriage to the middle ear before in vivo use. 2019-07-19 Thesis (University of Nottingham only) NonPeerReviewed application/pdf en arr https://eprints.nottingham.ac.uk/56413/1/Thesis%20post%20corrections%20clean.pdf Hoskison, Emma (2019) Studies on slow release antibiotic middle ear pellets. PhD thesis, University of Nottingham. Antibiotic loaded pellets
spellingShingle Antibiotic loaded pellets
Hoskison, Emma
Studies on slow release antibiotic middle ear pellets
title Studies on slow release antibiotic middle ear pellets
title_full Studies on slow release antibiotic middle ear pellets
title_fullStr Studies on slow release antibiotic middle ear pellets
title_full_unstemmed Studies on slow release antibiotic middle ear pellets
title_short Studies on slow release antibiotic middle ear pellets
title_sort studies on slow release antibiotic middle ear pellets
topic Antibiotic loaded pellets
url https://eprints.nottingham.ac.uk/56413/